466 related articles for article (PubMed ID: 17412323)
1. Cripto-1 expression in uveal melanoma: an immunohistochemical study.
Mallikarjuna K; Vaijayanthi P; Krishnakumar S
Exp Eye Res; 2007 Jun; 84(6):1060-6. PubMed ID: 17412323
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target.
All-Ericsson C; Girnita L; Seregard S; Bartolazzi A; Jager MJ; Larsson O
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):1-8. PubMed ID: 11773005
[TBL] [Abstract][Full Text] [Related]
3. Expression of epidermal growth factor receptor, ezrin, hepatocyte growth factor, and c-Met in uveal melanoma: an immunohistochemical study.
Mallikarjuna K; Pushparaj V; Biswas J; Krishnakumar S
Curr Eye Res; 2007 Mar; 32(3):281-90. PubMed ID: 17453948
[TBL] [Abstract][Full Text] [Related]
4. Possible implications of MCAM expression in metastasis and non-metastatic of primary uveal melanoma patients.
Beutel J; Wegner J; Wegner R; Ziemssen F; Nassar K; Rohrbach JM; Hilgers RD; Lüke M; Grisanti S
Curr Eye Res; 2009 Nov; 34(11):1004-9. PubMed ID: 19958117
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis inhibitor, survivin, in posterior uveal melanoma: comparison among primary tumors, tumors resistant to brachytherapy, tumors with liver metastases, and liver metastases.
Ben Simon GJ; Abulafia A; Pe'er J
Curr Eye Res; 2006 Mar; 31(3):251-7. PubMed ID: 16531282
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein 7 inhibits tumor growth of human uveal melanoma in vivo.
Notting I; Buijs J; Mintardjo R; van der Horst G; Vukicevic S; Lowik C; Schalij-Delfos N; Keunen J; van der Pluijm G
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4882-9. PubMed ID: 17962434
[TBL] [Abstract][Full Text] [Related]
7. Expression and distribution of MMPs and TIMPs in human uveal melanoma.
Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC
Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620
[TBL] [Abstract][Full Text] [Related]
8. Cripto monoclonal antibodies.
Hu XF; Xing PX
Drug News Perspect; 2005 Jun; 18(5):293-303. PubMed ID: 16193101
[TBL] [Abstract][Full Text] [Related]
9. Role of epidermal growth factor receptor in the metastasis of intraocular melanomas.
Ma D; Niederkorn JY
Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1067-75. PubMed ID: 9620065
[TBL] [Abstract][Full Text] [Related]
10. Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF).
Hendrix MJ; Seftor EA; Seftor RE; Kirschmann DA; Gardner LM; Boldt HC; Meyer M; Pe'er J; Folberg R
Am J Pathol; 1998 Apr; 152(4):855-63. PubMed ID: 9546344
[TBL] [Abstract][Full Text] [Related]
11. MMP-2 expression in uveal melanoma: differential activation status dictated by the cellular environment.
Bérubé M; Deschambeault A; Boucher M; Germain L; Petitclerc E; Guérin SL
Mol Vis; 2005 Dec; 11():1101-11. PubMed ID: 16379022
[TBL] [Abstract][Full Text] [Related]
12. Melanocortin 1 receptor is expressed by uveal malignant melanoma and can be considered a new target for diagnosis and immunotherapy.
López MN; Pereda C; Ramírez M; Mendoza-Naranjo A; Serrano A; Ferreira A; Poblete R; Kalergis AM; Kiessling R; Salazar-Onfray F
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1219-27. PubMed ID: 17325166
[TBL] [Abstract][Full Text] [Related]
13. Expression of insulin-like growth factor receptor (IGF-1R), c-Fos, and c-Jun in uveal melanoma: an immunohistochemical study.
Mallikarjuna K; Pushparaj V; Biswas J; Krishnakumar S
Curr Eye Res; 2006 Oct; 31(10):875-83. PubMed ID: 17050279
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Cripto and its prognostic significance in breast cancer: a study with long-term survival.
Gong YP; Yarrow PM; Carmalt HL; Kwun SY; Kennedy CW; Lin BP; Xing PX; Gillett DJ
Eur J Surg Oncol; 2007 May; 33(4):438-43. PubMed ID: 17125961
[TBL] [Abstract][Full Text] [Related]
15. Inverse correlation between expression of HLA-B and c-myc in uveal melanoma.
Blom DJ; Mooy CM; Luyten GP; Kerkvliet S; Ouwerkerk I; Zwinderman AH; Schrier PI; Jager MJ
J Pathol; 1997 Jan; 181(1):75-9. PubMed ID: 9072006
[TBL] [Abstract][Full Text] [Related]
16. Biologic determinants of uveal melanoma metastatic phenotype: role of intermediate filaments as predictive markers.
Hendrix MJ; Seftor EA; Seftor RE; Gardner LM; Boldt HC; Meyer M; Pe'er J; Folberg R
Lab Invest; 1998 Feb; 78(2):153-63. PubMed ID: 9484713
[TBL] [Abstract][Full Text] [Related]
17. Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma.
Errington JA; Conway RM; Walsh-Conway N; Browning J; Freyer C; Cebon J; Madigan MC
Br J Ophthalmol; 2012 Mar; 96(3):451-8. PubMed ID: 22190731
[TBL] [Abstract][Full Text] [Related]
18. GPNMB expression in uveal melanoma: a potential for targeted therapy.
Williams MD; Esmaeli B; Soheili A; Simantov R; Gombos DS; Bedikian AY; Hwu P
Melanoma Res; 2010 Jun; 20(3):184-90. PubMed ID: 20375921
[TBL] [Abstract][Full Text] [Related]
19. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type.
Paraoan L; Gray D; Hiscott P; Ebrahimi B; Damato B; Grierson I
Exp Eye Res; 2006 Oct; 83(4):911-9. PubMed ID: 16784742
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of chemokine receptors on uveal melanoma cells and their metastases.
Li H; Alizadeh H; Niederkorn JY
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):636-43. PubMed ID: 18235009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
